Department of Surgery, OLVG Hospital & Nederlandse Obesitas Kliniek [Dutch Obesity Clinic], Jan Tooropstraat 164, 1061 AE, Amsterdam, the Netherlands.
Department of Science, Nederlandse Obesitas Kliniek [Dutch Obesity Clinic], Huis Ter Heide, the Netherlands.
Obes Surg. 2024 Aug;34(8):2980-2990. doi: 10.1007/s11695-024-07381-4. Epub 2024 Jul 15.
The focus of measuring success in obesity treatment is shifting from weight loss to patients' health and quality of life. The objective of this study was to select a core set of patient-reported outcomes and patient-reported outcome measures to be used in clinical obesity care.
The Standardizing Quality of Life in Obesity Treatment III, face-to-face hybrid consensus meeting, including people living with obesity as well as healthcare providers, was held in Maastricht, the Netherlands, in 2022. It was preceded by two prior multinational consensus meetings and a systematic review.
The meeting was attended by 27 participants, representing twelve countries from five continents. The participants included healthcare providers, such as surgeons, endocrinologists, dietitians, psychologists, researchers, and people living with obesity, most of whom were involved in patient representative networks. Three patient-reported outcome measures (patient-reported outcomes) were selected: the Impact of Weight on Quality of Life-Lite (self-esteem) measure, the BODY-Q (physical function, physical symptoms, psychological function, social function, eating behavior, and body image), and the Quality of Life for Obesity Surgery questionnaire (excess skin). No patient-reported outcome measure was selected for stigma.
A core set of patient-reported outcomes and patient-reported outcome measures for measuring quality of life in clinical obesity care is established incorporating patients' and experts' opinions. This set should be used as a minimum for measuring quality of life in routine clinical practice. It is essential that individual patient-reported outcome measure scores are shared with people living with obesity in order to enhance patient engagement and shared decision-making.
肥胖治疗中衡量成功的重点正从减重转向患者的健康和生活质量。本研究的目的是选择一组核心的患者报告结局和患者报告结局测量指标，用于临床肥胖治疗。
2022 年，在荷兰马斯特里赫特举行了肥胖治疗质量标准化 III 面对面混合共识会议，参与者包括肥胖患者和医疗保健提供者。在此之前，还举行了两次跨国共识会议和一次系统评价。
会议有 27 名参与者参加，代表来自五个大陆的十二个国家。参与者包括外科医生、内分泌学家、营养师、心理学家、研究人员和肥胖患者等医疗保健提供者，其中大多数人参与了患者代表网络。选择了三种患者报告结局测量指标（患者报告结局）：体重对生活质量的影响简表（自尊）、BODY-Q（身体功能、身体症状、心理功能、社会功能、饮食行为和身体形象）和肥胖手术患者生活质量问卷（多余皮肤）。没有选择用于衡量耻辱感的患者报告结局测量指标。
本研究通过纳入患者和专家的意见，建立了用于临床肥胖治疗中衡量生活质量的一组核心患者报告结局和患者报告结局测量指标。在常规临床实践中，应将这组指标作为衡量生活质量的最低标准。与肥胖患者分享个体患者报告结局测量指标的评分至关重要，以增强患者的参与度和共同决策。
